Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
32.50
0.00 (0.00%)
At close: Jun 11, 2026
Bioqual Market Cap
Bioqual has a market cap or net worth of $29.07 million as of June 18, 2026. Its market cap has decreased by -35.00% in one year.
Market Cap
29.07M
Enterprise Value
49.25M
Revenue
42.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
$32.50
Market Cap Chart
Since October 24, 1990, Bioqual's market cap has increased from 370.55K to 29.07M, an increase of 7,744.70%. That is a compound annual growth rate of 13.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 29.07M | -50.83% |
| Dec 18, 2024 | 59.12M | -19.19% |
| Dec 30, 2022 | 73.16M | -21.35% |
| Dec 31, 2021 | 93.02M | 30.00% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Global Cord Blood | 127.35M |
| Interpace Biosciences | 43.63M |
| Aspira Women's Health | 21.58M |
| Longduoduo Company | 15.31M |
| Psychemedics | 13.46M |
| iMD Companies | 3.55M |
| Stella Diagnostics | 3.11M |
| Hypha Labs | 2.33M |